Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Humana Names Carolyn Tandy Chief Inclusion and Diversity Officer
Humana Names Carolyn Tandy Chief Inclusion and Diversity Officer


Leading health and well-being company Humana Inc. (NYSE: HUM) has named Carolyn Tandy to the position of Senior Vice President and Chief Inclusion and Diversity Officer. Tandy will be responsible

U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Olderhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older


Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease

Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform


Waters Corporation (NYSE:WAT) today introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced

Dexcom richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessung: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessung


DexCom, Inc. (Nasdaq: DXCM), der Weltmarktführer im Bereich der kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, hat heute während der 14. Internationalen Konferenz über

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancerhttps://www.cyansecurity.com/:
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer


Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO)

Dexcom Looks to the Future of Continuous Glucose Monitoring: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Looks to the Future of Continuous Glucose Monitoring


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the publication and presentation of two new studies during the 14

PQA Presents CarePlus Health Plans with its Excellence in Quality Award: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
PQA Presents CarePlus Health Plans with its Excellence in Quality Award


CarePlus Health Plans, Inc., Florida’s largest* 5 out of 5-star Medicare Advantage plan, has been recognized by the Pharmacy Quality Alliance (PQA) with its Excellence in Quality award for

Agilent Announces New SureSelect Human All Exon V8:
Agilent Announces New SureSelect Human All Exon V8


Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein coding

CenterWell Senior Primary Care Extends its Value-Based Care to People with Original Medicare: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
CenterWell Senior Primary Care Extends its Value-Based Care to People with Original Medicare


CenterWell Senior Primary Care, a fast-growing provider of whole-person, senior-focused healthcare, is participating in a new federal population health program that will allow CenterWell to extend

Agilent Presents Thought Leader Award to Professor Chris Elliott
Agilent Presents Thought Leader Award to Professor Chris Elliott


Agilent Technologies Inc. (NYSE: A) today announced that Chris Elliott has received an Agilent Thought Leader Award. Dr. Elliott is Professor of Food Safety in the School of Biological Sciences and

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis


Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand


Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in

Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:




  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas


Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that for the second consecutive year, it is ranked #1 in Florida and Texas in the J.D. Power ranking of Commercial

Dexcom Announces Upcoming Conference Presentation: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:




  • Jereme Sylvain, Executive Vice President and Chief

Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results:
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.525 billion for the second quarter ended April 30, 2021, an increase of 23% compared to the second quarter of 2020 and up 19% on a

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases


Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method

Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference
Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the

Health Canada Approves Quidel’s Sofia® SARS Antigen FIA Test for Screening of Asymptomatic Populations With Serial Testing
Health Canada Approves Quidel’s Sofia® SARS Antigen FIA Test for Screening of Asymptomatic Populations With Serial Testing


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that its

Pfizer Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine in Older Adultshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine in Older Adults


Pfizer Inc. (NYSE: PFE) today announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the coadministration of the

Agilent to Present at Jefferies Virtual Healthcare Conference
Agilent to Present at Jefferies Virtual Healthcare Conference


Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Jefferies Virtual Healthcare Conference on June 1. Details are included below:



Jefferies Virtual Healthcare

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY®, the companies’ COVID-19 vaccine

Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Announces Cash Dividend of 19.4 Cents per Share


Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on July 28, 2021, to all shareholders of record as of the close

Waters Corporation Celebrates the Life and Legacy of its Founder, Jim Waters
Waters Corporation Celebrates the Life and Legacy of its Founder, Jim Waters


Waters Corporation founder James L. Waters, a legendary inventor and pioneer in liquid chromatography whose work spurred a multi-billion-dollar industry and helped advance numerous scientific

2021 Bold Goal Progress Report Shows Humana Medicare Advantage Members Maintained Their Overall Health In 2020, Throughout Pandemic: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
2021 Bold Goal Progress Report Shows Humana Medicare Advantage Members Maintained Their Overall Health In 2020, Throughout Pandemic


Humana Inc. (NYSE: HUM) today unveiled its 2021 Bold Goal Progress Report, which details the company’s progress with its ambitious population health strategy launched in 2015 to improve the health